Mary Caffrey

Both Don Berwick, MD, MPP, and Jerry Avorn, MD, argue that staying silent in the current climate is a choice, and not a good one for physicians.

The American Diabetes Association update has recommendations that affect liraglutide, canagliflozin, and empagliflozin.

Infantile spasms are hard to diagnose, which can lead to treatment delays, according to the study authors.

Semaglutide, Novo Nordisk’s once-weekly glucagon-like peptide-1 (GLP-1) receptor agonist for type 2 diabetes (T2D), received FDA approval Tuesday, after beating its rival in a head-to-head trial and coming to the approval process with proof of cardiovascular benefits already in hand.

Sanofi’s newest insulin met its primary objective in a large head-to-head trial that compared it with its chief competitor.

Researchers at Duke University found there is substantial room for improvement in providing consumers with ready access to healthcare prices online.

The FDA update was based on results of the FOURIER trial, which showed the drug reduced the risk of heart attacks, strokes, and revascularizations in high-risk patients.

Scaling back the Comprehensive Care for Joint Replacement model and canceling an expansion proposed under the Obama administration represents a shift in philosophy from mandatory to voluntary bundled payment models. But some say that commercial payers and employers will demand change no matter what CMS does.

Liver and endometrial cancer accounted for high numbers of new cases; increases of these cancer types have been attributed to rising rates of diabetes and obesity.

The review period in the report bridged a public scandal at the VA that forced the resignation of a former Cabinet secretary.

The research shows that giving patients support to keep weight off after surgery is key to maintaining diabetes remission.

Chief Togetherness Officer Robin Caruso, LCSW, highlights early successes of CareMore's program to address lonelineness in the senior population.

The Beyond A1C movement seeks regulatory and clinical are frameworks that recognize the day-to-day measures that matter to patients, such as how often they experience hypoglycemia.

The Coverage2Control campaign has worked to convince payers of the value of life-saving technology and the need to control out-of-pocket costs.

Federal regulators are asking for information that will get to the bottom of how drug discounting between pharmaceutical companies and health plans affect what seniors pay at the pharmacy counter.

The evolution of the navigator role has been an important development in cancer care, according to panelists who offered various perspectives on helping patients along the cancer journey.

The first major update since 2003 was announced this week during the 2017 American Heart Association Scientific Sessions.

High chemotherapy costs are only one reason for the rising cost of cancer care. End-of-life care and hospitalizations are within an oncologist's control and must be better managed given new reimbursement structures.

FDA on Thursday authorized a faster approval path for a next-generation sequencing assay developed at Memorial Sloan Kettering Cancer Center (MSK) that represents both a scientific and regulatory breakthrough at the agency.

Reimbursement policy has been a driver of change in the way hospitals handle heart failure patients.

The findings, presented at the 2017 American Heart Association Scientific Sessions, suggest that a "precision medicine" approach to tailoring adherence strategies to individual patients may be needed, according to the study's lead author.

The analysis presented at the American Heart Association looks strictly at healthcare costs, but a broader cost-effectiveness study is planned that will consider drug costs as well as effect on patient quality of life.

Researchers presenting at the American Heart Association look at specific populations within 2 large diabetes drug trials, CANVAS and EMPA-REG OUTCOME.

The Gallup-Sharecare Wellbeing Index released its estimate of the cost of diabetes for employers on World Diabetes Day.

The technology allows patients to send a signal to caregivers or physicians through a web-based portal.

The chair of the guidelines committee said just because it's hard to change diet and exercise habits doesn't mean doctors and patients shouldn't try.

Results from higher-risk subgroups could help clinicians target this cholesterol-fighting therapy to patients who most need it, authors of one abstract say.

While consumers must buy coverage or face penalties under the individual mandate for now, there is speculation that a Trump tax plan could remove this feature of the Affordable Care Act.

For almost all adults who come into contact with Staphylococcus aureaus, the bacteria is harmless; but for a handful of people it is the cause of a debilitating, itchy red skin rash. Researchers at Johns Hopkins School of Medicine set out to learn more about this bacteria.